diabnext lauréat du prix CES innovation Award 2017

CLIPSULIN® Wins the CES Innovation Award 2017



DIABNEXT®’s CLIPSULIN® is a 2017 CES Innovation Award Winner in the BIOTECH category. CLIPSULIN® is part of DIABNEXT®, the world’s first Artificial Intelligence dedicated to Diabetes management with a suite of interactive data-analyzing software and hardware.

CLIPSULIN® is a smart connected insulin dose recorder designed to be compatible with different insulin pens from around the world. It automatically captures the number of units injected, as well as the date and time of injection. This saved metric is then transmitted to the DIABNEXT® mobile App and J.A.R.V.I.S. interface A.I., making the information easy to access and share with physicians, caregivers or community groups of patients using DIABNEXT A.I.

Please visit us at CES 2017 in Las Vegas, where we will be showing our full range of innovative products (booth VIGIHEALTH DIABNEXT®: 43430 – Sands Expo Center)